GEN Exclusives

More »

GEN News Highlights

More »
Jan 9, 2007

Organon Extends Research Interest in China

  • Huya Bioscience will support Organon in the sourcing and development Chinese pharmaceutical or biopharmaceutical compounds in three specific therapeutic areas. As part of this collaboration, Organon has acquired an equity interest in Huya.

    David Nicholson, executive vp R&D at Organon points out that this collaboration agreement “is consistent with our research strategy to forge closer links with China's highly skilled and motivated scientists and significantly expands our own ongoing biotech research programs and capabilities.”

    This transaction follows other research collaborations that Organon has signed with Chinese biotech companies, such as Shanghai Genomics and HD Biosciences.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »